121507-66-2Relevant articles and documents
Catalytic enantioselective conjugate addition of dialkylzinc reagents to N-substituted-2,3-dehydro-4-piperidones
Sebesta, Radovan,Pizzuti, Maria Gabriella,Boersma, Arnold J.,Minnaard, Adriaan J.,Feringa, Ben L.
, p. 1711 - 1713 (2005)
The first, highly enantioselective, copper/phosphoramidite-catalyzed conjugate addition of dialkylzinc reagents to N-substituted 2,3-dehydro-4- piperidones is described. The Royal Society of Chemistry 2005.
New oxidative demetalation protocol for molybdenum π-complexes: Enantiocontrolled synthesis of unsaturated ketones and lactones
Alcudia, Ana,Arrayas, Ramon Gomez,Liebeskind, Lanny S.
, p. 5773 - 5778 (2002)
An efficient and general oxidative demetalation of (η3-allyl)molybdenum complexes using pyridinium dichromate allows the introduction of a carbonyl group at an allylic terminus of the π-system. The process takes place with high regiocontrol and can lead to the preparation of unsaturated ketones and lactones of high enantiopurity.
Design, Synthesis, and Pharmacological Characterization of a Neutral, Non-Prodrug Thrombin Inhibitor with Good Oral Pharmacokinetics
Hillisch, Alexander,Gericke, Kersten M.,Allerheiligen, Swen,Roehrig, Susanne,Schaefer, Martina,Tersteegen, Adrian,Schulz, Simone,Lienau, Philip,Gnoth, Mark,Puetter, Vera,Hillig, Roman C.,Heitmeier, Stefan
supporting information, p. 12574 - 12594 (2020/11/13)
Despite extensive research on small molecule thrombin inhibitors for oral application in the past decades, only a single double prodrug with very modest oral bioavailability has reached human therapy as a marketed drug. We have undertaken major efforts to identify neutral, non-prodrug inhibitors. Using a holistic analysis of all available internal data, we were able to build computational models and apply these for the selection of a lead series with the highest possibility of achieving oral bioavailability. In our design, we relied on protein structure knowledge to address potency and identified a small window of favorable physicochemical properties to balance absorption and metabolic stability. Protein structure information on the pregnane X receptor helped in overcoming a persistent cytochrome P450 3A4 induction problem. The selected compound series was optimized to a highly potent, neutral, non-prodrug thrombin inhibitor by designing, synthesizing, and testing derivatives. The resulting optimized compound, BAY1217224, has reached first clinical trials, which have confirmed the desired pharmacokinetic properties.
REGIO- AND STEREOSELECTIVE ADDITION OF NUCLEOPHILES TO 1-PHENOXYCARBONYL-2,3-DIHYDROPYRIDINIUM SALTS
Comins, Daniel L.,Chung, Geewon,Foley, Michael, A.
, p. 1121 - 1140 (2007/10/02)
Several 2-alkyl-1-phenoxycarbonyl-Δ3-piperidines were prepared by the addition of alkylzinc iodides to dihydropyridinium salt (9).The treatment of 4-hydroxy-2-methyl-1-phenoxycarbonyl-1,2,3,4-tetrahydropyridine (12) with allyltrimethylsilane in the presence of a variety of Lewis acids was studied and found to give cis- and trans-2,6-dialkyl-Δ3-piperidines (14) and (15) in moderate to good yield.Among the Lewis acids studied, stannyl chloride gave the best yield with good stereoselectivity (84:16) favoring the cis-isomer (14).The analogous reaction of the 4-metho xy derivative (13) with organozinc reagents was examined and found to give the cis-isomers (17) as the major products.Using this metodology, the cis-piperidine alkaloid (+/-)-dihydropinidine, was prepared in six steps from 4-methoxypyridine.
THE ADDITION OF ALKYLZINC IODIDES TO 1-(PHENOXYCARBONYL)-2,3-DIHYDROPYRIDINIUM SALTS. A SYNTHESIS OF 2-ALKYL-Δ3-PIPERIDINES.
Comins, Daniel L.,Foley, Michael A.
, p. 6711 - 6714 (2007/10/02)
Several 2-alkyl-1-(phenoxycarbonyl)-Δ3-piperidines were prepared by the addition of alkylzinc iodides to 1-(phenoxycarbonyl)-2,3-dihydropyridinium salts.